General Information
Version
12
Revision date
2019-10-04
Product name
Cy3 Post-Labeling Reactive Dye Pack
1.2.1 Relevant identified uses
Use in laboratories
supplier name
Cytiva
Icons in SDS
Company Information
company name
Cytiva
e-mail address of the competent person responsible for the Safety Data Sheet
sds_author@cytiva.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H312, H317, H332, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mono-constituent substance
Signal word
Danger
Hazard statements
Harmful if swallowed, in contact with skin or if inhaled. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.
Prevention
Wear protective gloves. Wear protective clothing. Avoid breathing dust.
Response
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or physician.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings Not applicable.
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Acute Tox. 4, H302 Acute Tox. 4, H312 Acute Tox. 4, H332 Resp. Sens. 1, H334 Skin Sens. 1, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
